about
Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardationA systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardationThe COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteA census of human cancer genesMutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.COSMIC 2005Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardationArchitectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolutionMutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephalyMutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitusInhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinasesComprehensive predictive biomarker analysis for MEK inhibitor GSK1120212.Mutations of the BRAF gene in human cancerA germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndromeMutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremorFamilial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor geneCombined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinomaPatterns of somatic mutation in human cancer genomesIdentification of the breast cancer susceptibility gene BRCA2Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones.Cancer and genomics.A survey of RNA editing in human brainSystematic analysis of genotype-specific drug responses in cancer.A survey of homozygous deletions in human cancer genomes.Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardationPooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).Breast and ovarian cancer.Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.Lung cancer: intragenic ERBB2 kinase mutations in tumours.BRCA2 mutations in primary breast and ovarian cancers.The BRC repeats are conserved in mammalian BRCA2 proteins.Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene.Sequence analysis of the protein kinase gene family in human testicular germ-cell tumors of adolescents and adults.Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation.Statistical analysis of pathogenicity of somatic mutations in cancerSequence-based cancer genomics: progress, lessons and opportunities.Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.High-resolution analysis of DNA copy number using oligonucleotide microarrays.Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile.Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.
P50
Q24612060-0788E29C-12DE-42C5-BE22-9E73986B1D82Q24613870-B298FF28-B119-4CEA-88AD-45C2D1960C9CQ24645514-837EAD97-9021-47E5-A6F9-8752DE977397Q24647081-ED2A9FAD-966C-493B-918A-8084E72609E1Q24651919-33C9B289-7BA6-4812-AA0F-153B67981AC4Q24652464-FCCB6023-AA79-428A-8A3B-117739AB8FE9Q24671723-26706A4E-F9CC-458E-8F33-3D8543E32217Q24676904-5AF13E25-EF44-4577-A0AA-B7A7FBB7A94FQ24678235-0D41DBB1-1C8E-404B-B958-D9E79CAFA79CQ24682652-8A496E7D-5BD3-42C9-B231-E46796C86665Q27657708-F0DDC8C6-5ABB-4E43-9B7B-DD92A3437A81Q27851693-0600B15C-8A93-4715-B302-4D7ABE34B593Q27860760-2F446CEE-A085-46DF-9D37-54EEBF0D2A18Q28208102-E2B50A3D-5738-4C8A-8273-9317929005A7Q28284058-B711C9D7-8278-4167-8A30-F7755CF8A07BQ28284637-F048BD4A-F376-4A53-8358-875C54241397Q28728155-DF18F867-110B-49BF-A67F-96D565DEA113Q29547841-11333861-2A25-4295-953A-FB6B6908354FQ29616290-EE6C3432-65CF-4615-A5A0-31089A1B5F18Q30828856-78DBE376-AF67-4F10-B445-FBB018A2B814Q30982824-517D7DA0-78D8-47DF-8404-117A4C43414CQ31127917-86FFBC24-1C4E-4C39-B746-8BFBA42F36A2Q33575305-33BB5518-EC9D-413C-8FC8-FA364E27BC15Q33934322-287AA67D-D1ED-40AD-A843-D470556B9B80Q33998564-76F6B0C2-C039-497D-BE31-6E2BCD2A765DQ34128812-ECB60137-B250-4425-8BC3-561138A8F925Q34203363-5986EEA1-7518-4982-819C-B5C4E65A0425Q34334383-CA22761D-71F3-4390-A837-98AD40921FC2Q34354426-9B6F308E-2BED-4710-9259-89E7CB3489FAQ34381053-E9DE3AEB-0C60-4ACA-9BEF-EA2939FAE14EQ34413944-A7338388-4761-4DCA-B129-52AA53B8F98EQ34419177-7DB14022-2FF5-4D72-BEF5-934FC31E80A4Q34452597-4BAFCE0B-B476-4CDD-AD73-26B48C450AA7Q34581217-AC54D2E5-567A-4988-9F67-888223723261Q35038448-2174B870-2F41-4D3F-91EA-68B2C1CBDE92Q35140822-2D9B63A3-6110-4C92-BDFC-FEF529C7AAC6Q35248795-78D35476-4493-43A0-9AE5-FDC036BB3ADAQ35728773-A59A5225-7DAB-414F-81FE-2585A4F75803Q35918316-7D805208-FB6C-4BB6-89AF-44FA816A86FEQ36115517-D21EF7AE-55D7-4CA1-8F42-017B68D84A58
P50
description
onderzoeker
@nl
name
Richard Wooster
@ast
Richard Wooster
@en
Richard Wooster
@es
Richard Wooster
@fr
Richard Wooster
@nl
Richard Wooster
@sl
type
label
Richard Wooster
@ast
Richard Wooster
@en
Richard Wooster
@es
Richard Wooster
@fr
Richard Wooster
@nl
Richard Wooster
@sl
prefLabel
Richard Wooster
@ast
Richard Wooster
@en
Richard Wooster
@es
Richard Wooster
@fr
Richard Wooster
@nl
Richard Wooster
@sl